Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hester Biosciences Ltd Capital/Financing Update 2020

Nov 5, 2020

62222_rns_2020-11-05_88e8747e-7632-4cf8-b6eb-f1b56482b321.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [525 x 97] intentionally omitted <==

05.11.2020

To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 524669

To, National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051 Symbol: HESTERBIO

Respected Sir/Madam:

Subject: Intimation of assigned Credit Ratings

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulations"), we would like to inform that CARE Ratings Limited ('CARE Ratings'), vide it's letter dated 5 November 2020 (received through email), has assign the followings ratings to the Company:

Credit Facility Existing Ratings Revised Ratings Remark
Long - term BankFacilities " l" CARE "A- : Stable"(Single A Minus:Outlook: Stable) Reaffirmed
CARE A- : Stabe
(Single A Minus:
Otlk Stbl
uoo: ae)
Long - term /Short - term BankFacilities CARE "A- : Stable" / CARE "A- : Stable" / Reaffirmed
CARE "A2" CARE "A2"(Single A Minus:Outlook: Stable/ A Two)
(Single A Minus:
Outlook: Stable/ A Two)
Short - term BankFacilities CARE "A2" CARE "A2" Reaffirmed
(A Two) (A Two)

Kindly take note of the same and consider in your records.

Sincerely, For Hester Biosciences Limited Vinod Mali Company Secretary & Compliance Officer